China Gewang Biotechnology (CGWB) Inactive 10-Q2017 Q1 Quarterly report

Filed: 12 Apr 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	7th grade Avg

New words: additionally, amortization, amortized, atFebruary, bearingdemand, begun, Black, branded, Brown, Buckwheat, Chenzhou, Commerce, compensation, computed, consumer, conversion, cooperation, deferral, degree, distinct, eat, enable, encompassing, entertainment, expand, expanded, expanding, expended, exposed, extend, flower, food, forward, fringe, front, gap, greatest, greatly, healthy, hedge, higher, hope, Huayuda, improve, industry, institute, intend, introduced, janitorial, Jindanli, Kernel, label, led, life, long, Maintenance, Maize, monthly, negotiated, network, Ormosia, ownedapproximately, owner, paper, partnership, point, porridge, prepayment, processed, projected, Qianlifeng, quickly, ready, receipt, refer, refusal, relationship, replicated, research, resold, restaurant, Rice, Salary, seleniumenriched, SeleniumRich, September, Shangdong, spend, target, team, tendered, theCompany, Topic, travel, unamortized, uncertainty, uncollectable, unsatisfactory, upcoming

Removed: accelerated, addressed, aggregate, applied, arise, authoritative, BiotechnologyInternational, Chancheng, chapter, check, clothing, collectable, comparable, concept, designer, direct, doubt, electronically, eliminating, evaluate, extraordinary, filer, filing, footwear, Imputation, Interactive, issuance, Issuer, Jinsui, large, Li, managed, mark, negative, October, offering, Pearl, post, posted, practicable, presenting, private, profitability, prospectively, relating, remained, retrospectively, River, Road, set, shell, shorter, simplification, site, smaller, submit, submitted, substantial, sum, Telephone, terminated, Town, Unusual, Voting, Wang, Washington, Web, wholly, world, Xita

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CGWB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32: Rule 13a-14(b) Certification

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of China Gewang Biotechnology, Inc. (the “Company”) certify that:

1. The Quarterly Report on Form 10-Q of the Company for the period ended February 28, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 11, 2017	By:	/s/ Li Wang
		Li Wang, Chief Executive Officer

Date: April 11, 2017	By:	/s/ Ming Cheng
		Ming Cheng, Chief Financial Officer